2019
DOI: 10.1101/539403
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

UK phenomics platform for developing and validating EHR phenotypes: CALIBER

Abstract: Objective Electronic Health Records (EHR) are a rich source of information on human diseases, but the information is variably structured, fragmented, curated using different coding systems and collected for purposes other than medical research. We describe an approach for developing, validating and sharing reproducible phenotypes from national structured EHR in the United Kingdom (UK) with applications for translational research. Materials and MethodsWe implemented a rule-based phenotyping framework, with up t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
3

Relationship

4
3

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 93 publications
(82 reference statements)
0
10
0
Order By: Relevance
“…Subsequent studies will follow a stepwise strategy for phenotype definition to address HF subtypes based on aetiology, LVEF, and disease progression ( Figure ). Mobilizing HF subtype data from electronic health records, leveraging large genomic biobanks, will be necessary to ensure sufficient statistical power for subtype analysis, and this will be achieved through the deployment of validated multi‐modal rule‐based phenotyping algorithms 25 …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Subsequent studies will follow a stepwise strategy for phenotype definition to address HF subtypes based on aetiology, LVEF, and disease progression ( Figure ). Mobilizing HF subtype data from electronic health records, leveraging large genomic biobanks, will be necessary to ensure sufficient statistical power for subtype analysis, and this will be achieved through the deployment of validated multi‐modal rule‐based phenotyping algorithms 25 …”
Section: Methodsmentioning
confidence: 99%
“…Mobilizing HF subtype data from electronic health records, leveraging large genomic biobanks, will be necessary to ensure sufficient statistical power for subtype analysis, and this will be achieved through the deployment of validated multi-modal rule-based phenotyping algorithms. 25 Given the mortality associated with HF, inclusion of incident and prevalent cases in analyses may lead to attenuation of effect estimates, due to survivorship or collider bias and increased heterogeneity 26,27 ; however, this bias is partially mitigated by the increased power associated with a larger sample size that can be achieved when prevalent cases are included.…”
Section: Heart Failure Phenotype Definitionmentioning
confidence: 99%
“…This study will be carried out as part of the CALIBER programme. CALIBER, led from the UCL Institute of Health Informatics, is a research resource consisting of anonymised, coded variables extracted from linked electronic health records, methods and tools, specialised infrastructure, and training and support 11,12 .…”
Section: Ethical Approvalsmentioning
confidence: 99%
“…Previously established methods by CALIBER will be used for the development of a migration phenotype 12 . The CPRD code browsers will be searched for diagnostic terms relating to migration using the following search terms: *migrant*, *migrat*, *countr*, *asylum*, *refugee*, *visa*, *abroad*, *born in*, *origin*, *illegal*, *language*.…”
Section: Development Of Phenotypementioning
confidence: 99%
“…Historically, phenotypes have been inferred from rule-based algorithms using expert defined criteria from care guidelines and/or knowledge of clinical practice [11]. Because documentation varies substantially across phenotypes, providers, and institutions, developing a sufficient set of rules that encode how a condition may be documented in patient records is prohibitively resource intensive [12,13]. Moreover, the scope of rule-based algorithms is severely limited, particularly for more complex phenotypes recorded primarily in clinical notes [14][15][16].…”
Section: Introductionmentioning
confidence: 99%